• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYNCARDIA SYSTEMS, LLC SYNCARDIA 70CC TAH-T; BIVENTRICULAR REPLACEMENT DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYNCARDIA SYSTEMS, LLC SYNCARDIA 70CC TAH-T; BIVENTRICULAR REPLACEMENT DEVICE Back to Search Results
Model Number 500101-001
Device Problems Material Erosion (1214); Device Issue (2379)
Patient Problems Hemorrhage/Bleeding (1888); Liver Laceration(s) (1955)
Event Date 12/19/2017
Event Type  Injury  
Manufacturer Narrative
The tah-t will be returned to syncardia for evaluation.The results of the investigation will be provided in a follow-up mdr.(b)(4) initial.
 
Event Description
The customer, a syncardia certified hospital, reported that during exploratory surgery they determined that the cannulae of tah-t had eroded through the peritoneum into the dome of the left liver causing a liver laceration.The laceration caused slow bleeding into the mediastinum causing compression of the inferior vena cava.The customer also reported that the surgeons felt the only solution was to exchange the tah-t.The customer also reported that patient conditions (very thin and malnourished) contributed to the serious injury and they did not allege a device malfunction.The customer also reported that after the tah-t was replaced the patient was recovering well and "is like a whole new patient.".
 
Manufacturer Narrative
The cannulae were not returned with the tah-t ventricles and therefore could not be evaluated.An explant analysis was performed on the tah-t ventricles and did not reveal any anomalies or abnormalities.This issue will be monitored and trended as part of the customer experience process.Syncardia has completed its evaluation of this complaint and is closing this file.(b)(4).
 
Event Description
The customer, a syncardia certified hospital, reported that during exploratory surgery they determined that the cannulae of tah-t had eroded through the peritoneum into the dome of the left liver causing a liver laceration.The laceration caused slow bleeding into the mediastinum causing compression of the inferior vena cava.The customer also reported that the surgeons felt the only solution was to exchange the tah-t.The customer also reported that patient conditions (very thin and malnourished) contributed to the serious injury and they did not allege a device malfunction.The customer also reported that after the tah-t was replaced the patient was recovering well and "is like a whole new patient.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCARDIA 70CC TAH-T
Type of Device
BIVENTRICULAR REPLACEMENT DEVICE
Manufacturer (Section D)
SYNCARDIA SYSTEMS, LLC
1992 e. silverlake road
tucson AZ 85713
MDR Report Key7174874
MDR Text Key96727512
Report Number3003761017-2018-00004
Device Sequence Number1
Product Code LOZ
UDI-Device Identifier00858000003008
UDI-Public(01)00858000003008
Combination Product (y/n)N
PMA/PMN Number
P030011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Remedial Action Replace
Type of Report Initial,Followup
Report Date 12/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/09/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2020
Device Model Number500101-001
Device Catalogue Number500101
Device Lot Number110931
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/03/2018
Was the Report Sent to FDA? No
Date Manufacturer Received03/13/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age34 YR
-
-